Insider trading

Period: 120 months Stock: GYRE Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

39 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

39 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

39 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

39 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
39 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
39 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

39 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
18 Jun 2026
Ye Weiguo Chief Operating Officer
Sold at will
$19.05K 3,000 at 6.35
0.4%
Not planned
11 Jun 2026
Ye Weiguo Chief Operating Officer
Sold at will
$17.28K 2,800 at 6.17
0.4%
Not planned
10 Jun 2026
Ye Weiguo Chief Operating Officer
Sold at will 2×
$71.06K 11,418 at 6.22
1.6%
Not planned
9 Jun 2026
Ye Weiguo Chief Operating Officer
Sold at will 2×
$107.48K 17,500 at 6.14
2.4%
Not planned
5 Jun 2026
Ye Weiguo Chief Operating Officer
Sold at will
$98.57K 15,401 at 6.40
2.2%
Not planned
4 Jun 2026
Ye Weiguo Chief Operating Officer
Sold at will
$119.99K 19,575 at 6.13
2.7%
Not planned
26 May 2026
Ye Weiguo Chief Operating Officer
Sold at will
$24.40K 4,000 at 6.10
0.6%
Not planned
22 May 2026
Ye Weiguo Chief Operating Officer
Sold at will
$21.28K 3,500 at 6.08
0.5%
Not planned
21 May 2026
Ye Weiguo Chief Operating Officer
Sold at will
$78.84K 12,820 at 6.15
1.8%
Not planned
20 May 2026
Ye Weiguo Chief Operating Officer
Sold at will
$57.81K 9,400 at 6.15
1.3%
Not planned
19 May 2026
Ye Weiguo Chief Operating Officer
Sold at will
$58.09K 9,120 at 6.37
1.3%
Not planned
18 May 2026
Ye Weiguo Chief Operating Officer
Sold at will
$1.32K 200 at 6.62
0.0%
Not planned
15 May 2026
Ye Weiguo Chief Operating Officer
Sold at will
$87.12K 13,100 at 6.65
1.8%
Not planned
14 May 2026
Ye Weiguo Chief Operating Officer
Sold at will
$107.66K 15,580 at 6.91
2.2%
Not planned
9 Aug 2022
Blouse Grant E. Chief Scientific Officer
Bought
$1.53K 3,250 at 0.47
52.7%
+53% of stake
9 Aug 2022
Miller Seline E. SVP Finance; Interim CFO & PAO
Bought
$1.53K 3,250 at 0.47
100%
Largest buy in 3 yrs
9 Aug 2022
USMAN NASSIM President & CEO
Bought
$1.53K 3,250 at 0.47
15.3%
9 Feb 2022
USMAN NASSIM President & CEO
Bought
$1.50K 3,250 at 0.46
18.0%
9 Feb 2022
Blouse Grant E. Chief Scientific Officer
Bought
$1.50K 3,250 at 0.46
111%
+111% of stake
9 Feb 2022
Miller Seline E. SVP Finance; Interim CFO & PAO
Bought
$1.50K 3,250 at 0.46
opened
First buy on file
9 Aug 2021
Blouse Grant E. Chief Scientific Officer
Bought
$4.21K 1,163 at 3.62
66.3%
First buy on file
9 Aug 2021
USMAN NASSIM President & CEO
Bought
$3.14K 867 at 3.62
5.0%
Largest buy in 3 yrs
9 Aug 2021
Levy Howard Chief Medical Officer
Bought
$2.31K 639 at 3.62
opened
9 Feb 2021
Levy Howard Chief Medical Officer · indirect
Bought
$8.03K 1,670 at 4.81
7.7%
First buy on file
9 Feb 2021
USMAN NASSIM President & CEO
Bought
$2.80K 582 at 4.81
5.0%
First buy on file
10 Aug 2020
Levy Howard Chief Medical Officer
Bought
$8.50K 1,768 at 4.81
70.7%
First buy on file
10 Aug 2020
USMAN NASSIM President & CEO
Bought
$2.80K 582 at 4.81
5.3%
First buy on file
16 Mar 2020
Levy Howard Chief Medical Officer
Bought
$10.13K 2,500 at 4.05
opened
First buy on file
13 Mar 2020
USMAN NASSIM President & CEO
Bought
$15.65K 4,000 at 3.91
57.1%
First buy on file
13 Mar 2020
Richard John P Director
Bought
$9.95K 2,500 at 3.98
206%
First buy on file
13 Mar 2020
Cai Veronica Controller
Bought
$8.22K 2,000 at 4.11
37.4%
First buy on file
4 Mar 2020
Williams Eddie Director
Bought
$11.56K 2,000 at 5.78
22.6%
First buy on file
25 Feb 2020
LAWLOR AUGUSTINE Director · indirect
Sold, plan not stated
$423.51K 69,401 at 6.10
100%
Sold half or more
25 Feb 2020
Bought
$18.69K 3,000 at 6.23
opened
First buy on file
24 May 2019
Richard John P Director
Bought
$8.03K 1,000 at 8.03
463%
First buy on file
16 Nov 2018
Levy Howard Chief Medical Officer
Sold, plan not stated
$1.90K 173 at 11.00
2.2%
8 Mar 2018
Flynn James E 10% owner · indirect
Sold, plan not stated 2×
$271.63K 9,317 at 29.15
0.8%
7 Mar 2018
Flynn James E 10% owner · indirect
Sold, plan not stated
$300.00K 10,000 at 30.00
0.9%
6 Mar 2018
Flynn James E 10% owner · indirect
Sold, plan not stated 2×
$1.62M 52,461 at 30.87
4.4%
Showing 1–39 of 39.